Zenicor now listed by BNK Service as one of eight selected purchasing partners.
In April the first patients were included in the STROKESTOP 2 study. The aim of the study is to prevent stroke by screening for silent Atrial Fibrillation with Zenicor thumb-ECG and to initiate stroke preventive treatment. The study will include all 75 and 76 year old citizens in Stockholm.
A new large study, STROKESTOP II, will be conducted during 2016 and 2017.
The Norwegian paper Dagbladet puts the spotlight on screening for atrial fibrillation with Zenicor-ECG. READ MORE (Only in Norwegian)
The 24th of November 2015, Arrhythmia watch published an article about Zenicor thumb-ECG. READ THE ARTICLE
Charité University Hospital in Berlin presents a pediatric study with Zenicor EKG. “…an excellent diagnostic device for the detection and exclusion of tachycardia in children.” […]
On October 27, Tijn Hendrikx, general practitioner and MD made a presentation about the use of Zenicor Thumb-ECG. Tijn has done several studies on Zenicor […]
The internationally renowned journals Circulation and Europace have recently published two scientific articles from the Swedish STROKESTOP study on primary preventive screening for atrial fibrillation […]
We are glad to welcome our new colleagues Mira Pasanen and Barbara Hellfeuer into the Zenicor-team! Mira Pasanen will work as Country Sales Manager for […]
On March 23, 2015 Tijn Hendrikx, MD at the Vindelns health center and PHD student at the Department of Public Health and Clinical Medicine – […]
